Hyperinsulinemia increases placenta endothelin-converting enzyme-1 expression in trophoblasts

American Journal of Hypertension

Volumn 25, Issue 1, 2012, Pages 109-114

  Khamaisi, Mogher ^a   Skarzinski, Galia ^b   Mekler, Judith ^b   Zreik, Farid ^b   Damouni, Rawan ^a   Ariel, Ilana ^b   Bursztyn, Michael ^b  

^a RAMBAM MEDICAL CENTER   (Israel)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

blood pressure; endothelin; endothelin receptor; hyperinsulinemia; hypertension; intrauterine growth restriction; placenta; pregnancy induced hypertension; trophoblast

Indexed keywords

ENDOTHELIN CONVERTING ENZYME; ENDOTHELIN RECEPTOR; ENDOTHELIN RECEPTOR A; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; FETUS; FETUS WEIGHT; HEART; HYPERINSULINEMIA; HYPERTENSION; IMMUNOHISTOCHEMISTRY; KIDNEY; LIVER; LIVER LEVEL; MALE; MESOMETRIAL TRIANGLE; NONHUMAN; PLACENTA; PLACENTA WEIGHT; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TROPHOBLAST;

ANIMALS; ASPARTIC ACID ENDOPEPTIDASES; FEMALE; FETAL GROWTH RETARDATION; HYPERINSULINISM; METALLOENDOPEPTIDASES; PLACENTA; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; RATS; RATS, WISTAR; RECEPTOR, ENDOTHELIN A; TROPHOBLASTS;

EID: 83655201372     PISSN: 08957061     EISSN: 19417225     Source Type: Journal    
DOI: 10.1038/ajh.2011.164     Document Type: Article

References (28)

1. McMillen IC, Robinson JS. Developmental origins of the metabolic syndrome: prediction, plasticity, and programming. Physiol Rev 2005; 85:571-633. (Pubitemid 40404637)
2. Bursztyn M, Ariel I. Maternal-fetal deprivation and the cardiometabolic syndrome. J Cardiometab Syndr 2006; 1:141-145.
3. Barker DJ. The origins of the developmental origins theory. J Intern Med 2007; 261:412-417. (Pubitemid 46587729)
4. Brosens IA, Robertson WB, Dixon HG. The role of the spiral arteries in the pathogenesis of preeclampsia. Obstet Gynecol Annu 1972; 1:177-191.
5. Podjarny E, Bernheim J, Katz B, Green J, Mekler J, Bursztyn M. Chronic exogenous hyperinsulinemia in pregnancy: a rat model of pregnancy-induced hypertension. J Am Soc Nephrol 1998; 9:9-13. (Pubitemid 28050038)
6. Podjarny E, Bursztyn M, Rashed G, Benchetrit S, Katz B, Green J, Karmeli F, Peleg E, Bernheim J. Chronic exogenous hyperinsulinaemia-induced hypertension in pregnant rats: effect of chronic treatment with l-arginine. Clin Sci 2001; 100:667-671. (Pubitemid 32523321)
7. Bursztyn M, Podjarny E, Dahan R, Raz I, Bernheim J. Insulin-induced hypertension, L-arginine, and endothelial nitric oxide synthase in pregnant rats. Hypertens Pregnancy 2003; 22:267-274. (Pubitemid 37288690)
8. Helmbrecht GD, Farhat MY, Lochbaum L, Brown HE, Yadgarova KT, Eglinton GS, Ramwell PW. L-arginine reverses the adverse pregnancy changes induced by nitric oxide synthase inhibition in the rat. Am J Obstet Gynecol 1996; 175:800-805. (Pubitemid 26357932)
9. Bursztyn M, Gross ML, Goltser-Dubner T, Koleganova N, Birman T, Smith Y, Ariel I. Adult hypertension in intrauterine growth-restricted offspring of hyperinsulinemic rats: evidence of subtle renal damage. Hypertension 2006; 48:717-723. (Pubitemid 44843877)
10. Skarzinski G, Khamaisi M, Bursztyn M, Mekler J, Lan D, Evdokimov P, Ariel I. Intrauterine growth restriction and shallower implantation site in rats with maternal hyperinsulinemia are associated with altered NOS expression. Placenta 2009; 30:898-906.
11. Moore LG, Shriver M, Bemis L, Hickler B, Wilson M, Brutsaert T, Parra E, Vargas E. Maternal adaptation to high-altitude pregnancy: an experiment of nature-a review. Placenta 2004; 25 Suppl A:S60-S71. (Pubitemid 38514959)
12. Heyman SN, Khamaisi M, Rosen S, Rosenberger C. Renal parenchymal hypoxia, hypoxia response and the progression of chronic kidney disease. Am J Nephrol 2008; 28:998-1006.
13. Khamaisi M, Raz I, Shilo V, Shina A, Rosenberger C, Dahan R, Abassi Z, Meidan R, Lecht S, Heyman SN. Diabetes and radiocontrast media increase endothelin converting enzyme-1 in the kidney. Kidney Int 2008; 74:91-100. (Pubitemid 351841889)
14. Khamaisi M, Dahan R, Hamed S, Abassi Z, Heyman SN, Raz I. Role of protein kinase C in the expression of endothelin converting enzyme-1. Endocrinology 2009; 150:1440-1449.
15. Faxén M, Nasiell J, Lunell NO, Blanck A. Differences in mRNA expression of endothelin-1, c-fos and c-jun in placentas from normal pregnancies and pregnancies complicated with preeclampsia and/or intrauterine growth retardation. Gynecol Obstet Invest 1997; 44:93-96. (Pubitemid 27387328)
16. Thaete LG, Jilling T, Synowiec S, Khan S, Neerhof MG. Expression of endothelin 1 and its receptors in the hypoxic pregnant rat. Biol Reprod 2007; 77:526-532. (Pubitemid 47328616)
17. Hu RM, Levin ER, Pedram A, Frank HJ. Insulin stimulates production and secretion of endothelin from bovine endothelial cells. Diabetes 1993; 42:351-358. (Pubitemid 23045042)
18. Ferri C, Pittoni V, Piccoli A, Laurenti O, Cassone MR, Bellini C, Properzi G, Valesini G, De Mattia G, Santucci A. Insulin stimulates endothelin-1 secretion from human endothelial cells and modulates its circulating levels in vivo. J Clin Endocrinol Metab 1995; 80:829-835.
19. Cardillo C, Nambi SS, Kilcoyne CM, Choucair WK, Katz A, Quon MJ, Panza JA. Insulin stimulates both endothelin and nitric oxide activity in the human forearm. Circulation 1999; 100:820-825. (Pubitemid 29398879)
20. Gottschall PE, Ajmo JM, Eakin AK, Howell MD, Mehta H, Bailey LA. Panel of synaptic protein ELISAs for evaluating neurological phenotype. Exp Brain Res 2010; 201:885-893.
21. Khamaisi M, Keynan S, Bursztyn M, Dahan R, Reinhartz E, Ovadia H, Raz I. Role of renal nitric oxide synthase in diabetic kidney disease during the chronic phase of diabetes. Nephron Physiol 2006; 102:p72-p80. (Pubitemid 43289539)
22. Standaert ML, Sajan MP, Miura A, Kanoh Y, Chen HC, Farese RV Jr, Farese RV. Insulin-induced activation of atypical protein kinase C, but not protein kinase B, is maintained in diabetic (ob/ob and Goto-Kakazaki) liver. Contrasting insulin signaling patterns in liver versus muscle define phenotypes of type 2 diabetic and high fat-induced insulin-resistant states. J Biol Chem 2004; 279:24929-24934. (Pubitemid 38756740)
23. Thaete LG, Neerhof MG. Endothelin and platelet-activating factor: significance in the pathophysiology of ischemia/reperfusion-induced fetal growth restriction in the rat. Am J Obstet Gynecol 2006; 194:1377-1383.
24. Alexander BT, Rinewalt AN, Cockrell KL, Massey MB, Bennett WA, Granger JP. Endothelin type a receptor blockade attenuates the hypertension in response to chronic reductions in uterine perfusion pressure. Hypertension 2001; 37:485-489. (Pubitemid 32199016)
25. Murphy SR, LaMarca BB, Cockrell K, Granger JP. Role of endothelin in mediating soluble fms-like tyrosine kinase 1-induced hypertension in pregnant rats. Hypertension 2010; 55:394-398.
26. Kisanuki YY, Emoto N, Ohuchi T, Widyantoro B, Yagi K, Nakayama K, Kedzierski RM, Hammer RE, Yanagisawa H, Williams SC, Richardson JA, Suzuki T, Yanagisawa M. Low blood pressure in endothelial cell-specific endothelin 1 knockout mice. Hypertension 2010; 56:121-128.
27. Vicent D, Ilany J, Kondo T, Naruse K, Fisher SJ, Kisanuki YY, Bursell S, Yanagisawa M, King GL, Kahn CR. The role of endothelial insulin signaling in the regulation of vascular tone and insulin resistance. J Clin Invest 2003; 111:1373-1380. (Pubitemid 36554708)
28. Neerhof MG, Synowiec S, Khan S, Thaete LG. Impact of endothelin A receptor antagonist selectivity in chronic nitric oxide synthase inhibition-induced fetal growth restriction in the rat. Hypertens Pregnancy 2010; 29:284-293.